400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Metabolic Enzyme / PDE / PF-05180999
CAS No.: 1394033-54-5
Synonyms: PF-999;PF-5180999
PF 05180999 is a potent and selective PDE2A inhibitor with IC50 of 1 nM.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01530529 | Healthy | Phase 1 | Completed | - | United States, Connecticut ... more >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Collapse << |
NCT01429740 | Schizophrenia | Phase 1 | Completed | - | United States, Connecticut ... more >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Collapse << |
NCT01981486 | Migraine | Phase 1 | Withdrawn | January 2015 | - |
实验方案
技术信息
CAS号 | 1394033-54-5 | 储存条件 |
|
|
分子式 | C19H17F3N8 | 运输 | 蓝冰 | |
分子量 | 414.39 | 别名 | PF-999;PF-5180999 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01530529 | Healthy | Phase 1 | Completed | - | United States, Connecticut ... more >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Collapse << |
NCT01429740 | Schizophrenia | Phase 1 | Completed | - | United States, Connecticut ... more >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Collapse << |
NCT01981486 | Migraine | Phase 1 | Withdrawn | January 2015 | - |
NCT01981499 | Migraine | Phase 1 | Terminated(The trial was prema... more >>turely terminated on 01April2014 due to safety concerns.) Collapse << | - | United States, Minnesota ... more >> Pfizer Investigational Site St. Paul, Minnesota, United States, 55114 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网